These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9815215)

  • 1. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.
    Nagashunmugam T; Malamud D; Davis C; Abrams WR; Friedman HM
    J Infect Dis; 1998 Dec; 178(6):1635-41. PubMed ID: 9815215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
    Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
    Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human submandibular saliva specifically inhibits HIV type 1.
    Nagashunmugam T; Friedman HM; Davis C; Kennedy S; Goldstein LT; Malamud D
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):371-6. PubMed ID: 9075477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV infectivity by human saliva.
    Malamud D; Nagashunmugam T; Davis C; Kennedy S; Abrams WR; Kream R; Friedman HM
    Oral Dis; 1997 May; 3 Suppl 1():S58-63. PubMed ID: 9456659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple components contribute to ability of saliva to inhibit influenza viruses.
    White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
    Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.
    Habte HH; Mall AS; de Beer C; Lotz ZE; Kahn D
    Virol J; 2006 Nov; 3():99. PubMed ID: 17125499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human salivas on recombinant HIV-1 proteins.
    Archibald DW; Hebert CA; Gregory KL; Lewis GK
    Crit Rev Oral Biol Med; 1993; 4(3-4):475-8. PubMed ID: 8374000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lipids with proteins and glycoproteins in human saliva.
    Slomiany BL; Witas H; Murty VL; Slomiany A; Mandel ID
    J Dent Res; 1983 Jan; 62(1):24-7. PubMed ID: 6571849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Submandibular salivary proteases: lack of a role in anti-HIV activity.
    Kennedy S; Davis C; Abrams WR; Billings PC; Nagashunmugam T; Friedman H; Malamud D
    J Dent Res; 1998 Jul; 77(7):1515-9. PubMed ID: 9663436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.